L Santos-Argumedo - JoVE Visualize

Showing results (21-30 of 38) with videos related to

Pageof 4

Sort By:

Vaccine|June 5, 2007

A fusogenic peptide expressed on the surface of Salmonella enterica elicits CTL responses to a dengue virus epitopeR Luria-Perez, L Cedillo-Barron, L Santos-Argumedo, et al.

Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|February 19, 2008

Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigensL Lazaro-Olán, G Mellado-Sánchez, J García-Cordero, et al.

Hybridoma (2005)|June 10, 2005

Production and characterization of a monoclonal antibody specific for NS3 protease and the ATPase region of Dengue-2 virusJ García-Cordero, H Romero Ramirez, M Vazquez-Ochoa, et al.

International Immunology|February 1, 1995

CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transductionL Santos-Argumedo, F E Lund, A W Heath, et al.

Clinical Genetics|August 22, 2015

Functional characterization of two new STAT3 mutations associated with hyper-IgE syndrome in a Mexican cohortJ C Alcántara-Montiel, T Staines-Boone, G López-Herrera, et al.

Cytoskeleton (Hoboken, N.J.)|April 24, 2016

Myo1g is an active player in maintaining cell stiffness in B-lymphocytesO López-Ortega, E Ovalle-García, I Ortega-Blake, et al.

Scientific Reports|March 31, 2021

Myo1g is required for efficient adhesion and migration of activated B lymphocytes to inguinal lymph nodesD Cruz-Zárate, O López-Ortega, D A Girón-Pérez, et al.

Science (New York, N.Y.)|November 12, 1993

Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38M Howard, J C Grimaldi, J F Bazan, et al.

Cellular Immunology|December 1, 1993

Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cellsA W Heath, R Chang, N Harada, et al.

Allergologia Et Immunopathologia|January 12, 2013

Lymphocytes and B-cell abnormalities in patients with common variable immunodeficiency (CVID)L Berrón-Ruiz, G López-Herrera, A Vargas-Hernández, et al.

Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:

Pageof 4

Vaccine|June 5, 2007

A fusogenic peptide expressed on the surface of Salmonella enterica elicits CTL responses to a dengue virus epitopeR Luria-Perez, L Cedillo-Barron, L Santos-Argumedo, et al.

Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|February 19, 2008

Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigensL Lazaro-Olán, G Mellado-Sánchez, J García-Cordero, et al.

Hybridoma (2005)|June 10, 2005

Production and characterization of a monoclonal antibody specific for NS3 protease and the ATPase region of Dengue-2 virusJ García-Cordero, H Romero Ramirez, M Vazquez-Ochoa, et al.

International Immunology|February 1, 1995

CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transductionL Santos-Argumedo, F E Lund, A W Heath, et al.

Clinical Genetics|August 22, 2015

Functional characterization of two new STAT3 mutations associated with hyper-IgE syndrome in a Mexican cohortJ C Alcántara-Montiel, T Staines-Boone, G López-Herrera, et al.

Cytoskeleton (Hoboken, N.J.)|April 24, 2016

Myo1g is an active player in maintaining cell stiffness in B-lymphocytesO López-Ortega, E Ovalle-García, I Ortega-Blake, et al.

Scientific Reports|March 31, 2021

Myo1g is required for efficient adhesion and migration of activated B lymphocytes to inguinal lymph nodesD Cruz-Zárate, O López-Ortega, D A Girón-Pérez, et al.

Science (New York, N.Y.)|November 12, 1993

Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38M Howard, J C Grimaldi, J F Bazan, et al.

Cellular Immunology|December 1, 1993

Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cellsA W Heath, R Chang, N Harada, et al.

Allergologia Et Immunopathologia|January 12, 2013

Lymphocytes and B-cell abnormalities in patients with common variable immunodeficiency (CVID)L Berrón-Ruiz, G López-Herrera, A Vargas-Hernández, et al.

Pageof 4